Pathophysiology
Ectopic pulmonary vein foci initiate; atrial fibrosis, hypertension, obesity, OSA sustain. Loss of atrial kick reduces cardiac output; stasis in LA appendage causes thrombus.
Sources: AHA/ACC AFib 2023 (Circulation 2024;149:e1); EAST-AFNET (NEJM 2020;383:1305)
Presentation
Palpitations, dyspnoea, fatigue, angina, dizziness or syncope; asymptomatic in ~30% (silent AF). Rapid ventricular rate can precipitate heart failure.
Diagnosis
ECG: irregularly irregular rhythm without discrete P waves. Assess CHA2DS2-VASc for stroke risk and HAS-BLED for bleeding risk; echocardiogram; TSH.
Management
Rate control: beta-blockers or non-dihydropyridine CCBs (or digoxin). Rhythm control: catheter ablation (pulmonary vein isolation) first-line if paroxysmal/symptomatic per 2023 AHA. Anticoagulation with DOAC if CHA2DS2-VASc >=2 (men) or >=3 (women). LAA occlusion (Watchman) if contraindicated to anticoagulation.






